EHHADH

Chr 3AD

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

Also known as: ECHD, FRTS3, L-PBE, LBFP, MFE1, PBFE

The protein encoded by this gene is a bifunctional enzyme and is one of the four enzymes of the peroxisomal beta-oxidation pathway. The N-terminal region of the encoded protein contains enoyl-CoA hydratase activity while the C-terminal region contains 3-hydroxyacyl-CoA dehydrogenase activity. Defects in this gene are a cause of peroxisomal disorders such as Zellweger syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

OMIMResearchGenerating clinical summary…
DNmechanismADLOEUF 0.971 OMIM phenotype
Clinical SummaryEHHADH
🧬
Gene-Disease Validity (ClinGen)
Fanconi renotubular syndrome 3 · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
174 VUS of 276 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.97LOEUF
pLI 0.000
Z-score 1.68
OE 0.66 (0.460.97)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.03Z-score
OE missense 1.00 (0.921.09)
394 obs / 392.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.66 (0.460.97)
00.351.4
Missense OE?1.00 (0.921.09)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 19 / 28.7Missense obs/exp: 394 / 392.6Syn Z: 0.69

This gene — mechanism propensity

DN
0.7033th %ile
GOF
0.5071th %ile
LOF
0.3067th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNEhhadh knockout mice showed no abnormalities in renal tubular cells, a finding that indicates a dominant negative nature of the mutation rather than haploinsufficiency.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 24401050

ClinVar Variant Classifications

276 submitted variants in ClinVar

Classification Summary

VUS174
Likely Benign39
Benign31
Conflicting22
174
VUS
39
Likely Benign
31
Benign
22
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
17
138
3
16
174
Likely Benign
1
12
3
23
39
Benign
0
10
17
4
31
Conflicting
22
Total181602343266

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

43 pathogenic / likely-pathogenic (of 47) ClinVar copy-number / structural variants overlap EHHADH — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

EHHADH · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →